Justin’s work spans the full product life cycle, from negotiating research and development agreements, licenses, and government contracts to guiding clients through GxP compliance, expedited approval pathways, and product labeling considerations. When it’s time to bring a product to market, he helps clients evaluate marketing strategies, exclusivity claims, and promotional efforts while also advising on potential legislative and regulatory changes that may impact their industry.
Before joining Venable, Justin served as the primary legal advisor on regulated medical products to the U.S. military’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) as a member of the Office of the Staff Judge Advocate, U.S. Army Medical Research and Development Command (USAMRDC). There he shepherded medical countermeasures and other priority public health products through the FDA regulatory process, helping his clients develop the novel strategies necessary to secure approvals, licensures, clearances, authorizations, and label expansions. He also negotiated development agreements with private industry partners employing a variety of federal government contract vehicles, including Federal Acquisition Regulation (FAR) contracts, Other Transaction Authority (OTA) agreements, Cooperative Research and Development agreements (CRADAs), cooperative agreements and grants, material transfer agreements, and licenses.
During the COVID-19 pandemic, Justin led successful negotiations on research and development contracts for vaccines, therapeutics, and diagnostics contracted through Operation Warp Speed (OWS) and the federal government response, contributing to the more than $83 billion in contracts awarded by the JPEO-CBRND.
Before that, he worked for the U.S. Senate Committee on Finance, where he performed healthcare and tax oversight, and the Social Security Administration (SSA) Office of General Counsel (OGC), where he focused on federal government contract formation and litigation. Justin also has litigation experience with the False Claims Act (FCA) and Anti-Kickback Statute (AKS), product liability risks, and alternative dispute resolution, gained during his time at an international law firm.